Filing Details
- Accession Number:
- 0001127602-20-029930
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-11-24 16:24:11
- Reporting Period:
- 2020-11-23
- Accepted Time:
- 2020-11-24 16:24:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1682852 | Moderna Inc. | MRNA | Biological Products, (No Disgnostic Substances) (2836) | 813467528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1690927 | Zvi Tal Zaks | C/O Moderna, Inc. 200 Technology Square Cambridge MA 02139 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-11-23 | 5,000 | $12.21 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-11-23 | 10,000 | $19.15 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-11-23 | 1,440 | $99.31 | 13,560 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-23 | 6,836 | $100.12 | 6,724 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-11-23 | 6,724 | $101.21 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-23 | 5,000 | $0.00 | 5,000 | $12.21 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-11-23 | 10,000 | $0.00 | 10,000 | $19.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,945 | 2027-02-23 | No | 4 | M | Direct | |
| 34,790 | 2026-08-10 | No | 4 | M | Direct |
Footnotes
- The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on March 13, 2020.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $98.70 to $99.70. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $99.72 to $100.67. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $100.78 to $101.49. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- 25% of this option vested and became exercisable on February 22, 2018 with the remainder vesting in 12 equal quarterly installments thereafter.
- This option is fully vested and exercisable.
Billionaire Hedge Funds
